Syntax Research, Inc. Medtronic PLC Transaction History
Syntax Research, Inc.
- $141 Billion
- Q2 2025
A detailed history of Syntax Research, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Syntax Research, Inc. holds 6,523 shares of MDT stock, worth $606,247. This represents 0.4% of its overall portfolio holdings.
Number of Shares
6,523
Previous 5,877
10.99%
Holding current value
$606,247
Previous $528 Million
7.67%
% of portfolio
0.4%
Previous 0.36%
Shares
8 transactions
Others Institutions Holding MDT
# of Institutions
2,438Shares Held
1.06BCall Options Held
10.3MPut Options Held
9.61M-
Vanguard Group Inc Valley Forge, PA125MShares$11.6 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY112MShares$10.4 Billion0.2% of portfolio
-
State Street Corp Boston, MA60MShares$5.58 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.6MShares$3.86 Billion0.85% of portfolio
-
Jpmorgan Chase & CO New York, NY37.6MShares$3.5 Billion0.27% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $124B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...